Ventricular tachycardia in "end stage" hypertrophic cardiomyopathy: a role of dronedarone

被引：0

作者：

Nanda, S. ^{[1
]}

Levin, V. ^{[1
]}

Martinez, M. W. ^{[1
]}

机构：

[1] Lehigh Valley Hlth Network, Div Cardiovasc Med, Allentown, PA 18103 USA

来源：

MINERVA CARDIOANGIOLOGICA | 2012年 / 60卷 / 06期

关键词：

Cardiomyopathy; hypertrophic; Death; sudden; cardiac; Dronedarone; Tachycardia; ventricular; ATRIAL-FIBRILLATION; AMIODARONE; HEART; REPERFUSION; ARRHYTHMIAS; PREVALENCE; SURVIVAL; ISCHEMIA; SR-33589; THERAPY;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hypertrophic cardiomyopathy (HCM) occurs in 1 in every 500 individuals. It represents the most common cause of sudden cardiac death in those under the age of twenty-five. 3-5% patients with HCM go on to develop the dilated, hypokinetic end stage (ES) HCM with systolic failure. They have a higher incidence of heart failure, sudden deaths and defibrillator shocks. To the best of our knowledge this is first report of successful use of dronedarone for suppression of VT associated with ES HCM.

引用

页码：637 / 641

页数：5

共 50 条

[41] Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy
McLellan, Alex J. A.
Ellims, Andris H.
Prabhu, Sandeep
Voskoboinik, Alex
Iles, Leah M.
Hare, James L.
Kaye, David M.
Macciocca, Ivan
Mariani, Justin A.
Kalman, Jonathan M.
Taylor, Andrew J.
Kistler, Peter M.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2016, 27 (05) : 571 - 580
[42] Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy
Wang, Weijia
Lian, Zhesi
Rowin, Ethan J.
Maron, Barry J.
Maron, Martin S.
Link, Mark S.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2017, 10 (03)
[43] Dilated phase of hypertrophic cardiomyopathy caused by Fabry disease with atrial flutter and ventricular tachycardia
Fukuzawa, Koji
Yoshida, Akihiro
Onishi, Tetsuari
Suzuki, Atsushi
Kanda, Gaku
Takami, Kaoru
Kumagai, Hiroyuki
Torii, Satoko
Takami, Mitsuru
Fukuda, Yuko
Kawai, Hiroya
Hirata, Ken-ichi
JOURNAL OF CARDIOLOGY, 2009, 54 (01) : 139 - 143
[44] The prognostic role of right ventricular dysfunction in patients with hypertrophic cardiomyopathy
Mushtaq, Saima
Monti, Lorenzo
Rossi, Alexia
Pontone, Gianluca
Conte, Edoardo
Nicoli, Flavia
di Odoardo, Luca
Guglielmo, Marco
Indolfi, Eleonora
Bombace, Sara
Baggiano, Andrea
Gripari, Paola
Pepi, Mauro
Bartorelli, Antonio
Oliveira, Margarida
Santos, Ana
Francone, Marco
Andreini, Daniele
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2023, 39 (08) : 1515 - 1523
[45] Right ventricular involvement in feline hypertrophic cardiomyopathy
Schober, K. E.
Savino, S. I.
Yildiz, V.
JOURNAL OF VETERINARY CARDIOLOGY, 2016, 18 (04) : 297 - 309
[46] Discrepant Measurements of Maximal Left Ventricular Wall Thickness Between Cardiac Magnetic Resonance Imaging and Echocardiography in Patients With Hypertrophic Cardiomyopathy
Hindieh, Waseem
Weissler-Snir, Adaya
Hammer, Helene
Adler, Arnon
Rakowski, Harry
Chan, Raymond H.
CIRCULATION-CARDIOVASCULAR IMAGING, 2017, 10 (08)
[47] High-Resolution ECG for Predicting Ventricular Arrhythmia in Hypertrophic Cardiomyopathy: Another Tool in the Toolbox
Gehi, Anil K.
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (23):
[48] Left ventricular hypertrophy in the cat - "when hypertrophic cardiomyopathy is not hypertrophic cardiomyopathy"
Glaus, T. M.
Wess, G.
SCHWEIZER ARCHIV FUR TIERHEILKUNDE, 2010, 152 (07): : 325 - 330
[49] Ventricular arrhythmias and the role of antitachycardia pacing in patients with electrical heart disease and hypertrophic cardiomyopathy
Kantenwein, Verena
Pavaci, Herribert
Haller, Bernhard
Telishevska, Marta
Friedrich, Lena
Walgenbach, Maximilian
Lennerz, Carsten
Kolb, Christof
INTERNATIONAL JOURNAL OF CARDIOLOGY CONGENITAL HEART DISEASE, 2025, 19
[50] Catheter Ablation of Ventricular Tachycardia in Patients with Post-Infarction Cardiomyopathy
Nazer, Babak
Gerstenfeld, Edward P.
KOREAN CIRCULATION JOURNAL, 2014, 44 (04) : 210 - 217

← 1 2 3 4 5 →